ProKidney Corp. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
ProKidney Corp. (PROK) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $17.53 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-18
- ProKidney Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $17.53M, a 152.99% increase from fiscal 2024.
- ProKidney Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $6.93M, a 46.24% decline from fiscal 2023.
- ProKidney Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $12.89M, a 286.79% increase from fiscal 2022.
- ProKidney Corp. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $3.33M, a 169.36% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $17.53M 10-K · filed 2026-03-18 |
| 2024-12-31 | $6.93M 10-K · filed 2026-03-18 |
| 2023-12-31 | $12.89M 10-K · filed 2025-03-17 |
| 2022-12-31 | $3.33M 10-K · filed 2024-03-22 |
| 2021-12-31 | $1.24M 10-K · filed 2023-03-28 |